Drugs / Autologous Dendritic Cells (DC) vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04523688 | Mar 2021 → Jul 2025 overdue | glioblastoma | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Dendritic Cells (DC) vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04523688 ↗ |